Skip to content

SELLAS Life Sciences Group, Inc. SLS Balance Sheet Statement

FY'25FY'24FY'23FY'22
$71.79M+417%$13.89M+449%$2.53M-85.2%$17.13M-19.8%
$75.21M+361%$16.33M+415%$3.17M-82.1%$17.76M-22.9%
$1.91M0.0%$1.91M0.0%$1.91M0.0%$1.91M0.0%
$78.35M+303%$19.43M+212%$6.22M-70.3%$20.94M-20.3%
$2.95M-15.8%$3.5M-37.9%$5.64M+68.0%$3.36M+56.6%
$7.02M-26.2%$9.51M-30.8%$13.74M-11.5%$15.52M+211%
$7.47M-25.0%$9.97M-29.8%$14.2M-11.8%$16.09M+171%
$15K+114%$7K+133%$3K+50.0%$2K0.0%
-$274.99M-10.8%-$248.13M-14.2%-$217.24M-20.8%-$179.9M-29.8%
$70.87M+649%$9.47M+219%-$7.98M-264%$4.85M-76.2%
$78.35M+303%$19.43M+212%$6.22M-70.3%$20.94M-20.3%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are SELLAS Life Sciences Group, Inc.'s total assets?
SELLAS Life Sciences Group, Inc. (SLS) holds $114.2M in total assets, up 226.6% year over year.
How much debt does SELLAS Life Sciences Group, Inc. have?
SELLAS Life Sciences Group, Inc. carries $871.0K in total debt against $107.4M of shareholders' equity, a debt-to-equity ratio of 0.01.
How much cash does SELLAS Life Sciences Group, Inc. have?
SELLAS Life Sciences Group, Inc. holds $107.1M in cash and equivalents.
Can SELLAS Life Sciences Group, Inc. cover its short-term obligations?
Its current ratio is 17.22 — current assets exceed current liabilities.
Where does SELLAS Life Sciences Group, Inc.'s balance sheet data come from?
Every line is extracted from SELLAS Life Sciences Group, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.